CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication. The orally administered drug from Britain’s GW Pharmaceuticals previously was approved by the FDA to treat seizures associated with two forms of severe epilepsy, Lennox-Gastaut […]
You may also like
About the author
Steve serves as the founding editor of Hemp Stash News. With over 10 years experience in the news publishing business he decided to extend his vast portfolio by editing and publishing news about the Cannabis industry. Steve has a bachelor's degree in Journalism from the Northern Arizona University.
Steve can be reached out at: Steve.Morrison@hempstashnews.com